Breakthrough for teen who lost four family members to inherited condition
Mary Catchpole, 19, also has activated PI3-Kinase delta syndrome (APDS), a rare inherited disorder that leaves people with a significantly weakened immune system.
Patients with APDS are vulnerable to recurrent infections, often facing a lifetime of antibiotics and invasive medical procedures in an attempt to manage their health.
Miss Catchpole's mother's side of the family has been badly affected by APDS – her mother Sarah died aged 43 in 2018, her aunt Helen died aged 12, her uncle Edward when he was 39 and her grandmother Mary when she was 48.
Now, thanks to researchers in Cambridge who identified APDS, Miss Catchpole has received a new drug to treat it at Addenbrooke's Hospital in Cambridge.
The medicine, called leniolisib (Joenja), is the first ever targeted treatment for APDS and is a simple tablet taken twice a day.
Miss Catchpole is a teaching assistant who lives in Great Yarmouth with her father, Jimmy, 64, and brother Joe, 20, who does not have the condition.
'I was diagnosed with APDS aged seven, and it's had a big effect on my life. I had lots of cannulas when I was younger and lots of hospital trips,' she said.
'I had a permanent line in the side of my body when I was younger, which they put medicine in regularly at the hospital.
'I wasn't allowed to do very much physical activity, so I had to sit out a lot in PE at school.
'I used to be called an attention-seeker because obviously it was hidden, so no one really believed me.
'It also stopped me from doing a lot of my dancing, which I've always loved to do. So it has been hard.'
Miss Catchpole said taking the new drug is 'life-changing' as it means she can leave behind huge amounts of medication.
'I feel really blessed because it's so simple to do and it doesn't take up very much time, whereas for the medication, it just takes such a long time to do. So it's really a blessing, but it's also obviously bittersweet because my late family members never got the chance to have it.'
APDS was identified by Cambridge researchers in 2013, with Miss Catchpole's family playing a key role in its discovery.
Her mother and uncle were Addenbrooke's patients and were offered DNA sequencing to see if there was a genetic cause for their immunodeficiency.
Researchers identified a change in their genes that increased activity of an enzyme called PI3-Kinase delta, meaning this enzyme is effectively 'switched on' all the time. This prevents immune cells from fighting infection and leads to an abnormal immune function.
The new drug works by inhibiting the enzyme, effectively normalising the immune system.
Now, Miss Catchpole says she can look to the future with optimism and is excited to lead a normal life.
'I really want to become a dance teacher,' she said. 'I absolutely love my current job as a teaching assistant, but I'd also like to go on some adventures as well.
'I've always felt different, so it will be nice to feel like I belong.
'When I had sleepovers when I was younger and had to take all my medication with me, I didn't feel like a normal child.
'To be able to feel normal going about my day-to-day life is going to be really nice.'
Until now, the only treatments for APDS patients were antibiotics for infections, immunoglobulin replacement therapy to prevent infections and organ damage, and a bone marrow or stem cell transplant.
Dr Anita Chandra, consultant immunologist at Addenbrooke's and affiliated assistant professor at the University of Cambridge, said going from 'the discovery of a new disease in Cambridge to a treatment being approved and offered on the NHS within the space of 12 years' is 'incredible'.
'This new drug will make a huge difference to people living with APDS.'
Professor Sergey Nejentsev, from the University of Cambridge, who led the research that discovered APDS, said: 'As soon as we understood the cause of APDS, we immediately realised that certain drugs could be used to inhibit the enzyme that is activated in these patients.
'Leniolisib does precisely that. I am delighted that we finally have a treatment which will change the lives of APDS patients.'
Professor James Palmer, NHS England 's medical director for specialised commissioning, said: 'We're delighted to see Mary become the first patient in Europe to receive this first-ever targeted and approved therapy for a rare condition identified just over a decade ago – in Cambridge, no less.
'This treatment could be life-changing for those affected by this debilitating genetic disorder, and this important step forward is another example of the NHS's commitment to offering access to innovative medicines for those living with rare conditions.'
Experts believe the drug will work long-term in patients as long as they keep taking the tablets.
Researchers are now looking at the potential for leniolisib to work on other, more common immune conditions.
Patients eligible for leniolisib can be referred to Addenbrooke's for specialist review and care.
Between 40 to 50 people in England are known to have APDS.
The list price for leniolisib is £352,000 per person per year, but the company Pharming has agreed a discount for the NHS.
The team that discovered APDS included researchers from the University of Cambridge, Babraham Institute, Medical Research Council (MRC) Laboratory for Molecular Biology, and Addenbrooke's, with funding from Wellcome and the National Institute for Health and Care Research (NIHR).
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business News Wales
29 minutes ago
- Business News Wales
Porthcawl Optician Launches New Service and Celebrates 20 Years with Specsavers
A Porthcawl optician is marking 20 years of serving the community by launching a specialist clinic to support patients with sight loss as part of the NHS funded Low Vision Service. According to the UK's leading sight loss charity, the Royal National Institute of Blind People, around two million people are currently living with sight loss in the UK. The charity also predicts that by 2050, one person will lose their sight every three minutes. The low vision assessment service is funded by the NHS and will be overseen in Porthcawl by Specsavers director Louise Whiffin. The service aims to support those with reduced vision to maximise their remaining sight by offering tailored support and visual aids, like magnifiers and specialist lighting, as well as practical advice. It is available via accredited clinicians throughout Wales. This coincides with Louise's 20th anniversary at Specsavers after joining the business in 2005 as an optical assistant at the Swansea store. She has progressed through a variety of roles during her tenure at Specsavers, including dispensing optician and dispensing manager, before moving to the Porthcawl store in November 2022 to become a director. Over the course of her career Louise has earned multiple certifications including those in dispensing optics, British Sign Language and mental health first aid. Earlier this month, she became a fully qualified contact lens optician. Louise said: 'I'm thrilled to be celebrating 20 years at Specsavers by launching our new low vision service. 'The industry has evolved so much over the past two decades, and there are now more opportunities than ever for us to expand our services and help even more people in the area improve their eye sight. 'I'm excited to see how we can continue to adapt and thrive as a store, ensuring we provide the very best service to our customers.'
Times
an hour ago
- Times
Families hit by Britain's worst scandals face inheritance tax threat
Families of the victims of two of Britain's worst scandals face an inheritance tax sting on their compensation. Ministers had promised that money paid to dead victims of the Post Office and infected blood scandals would be free from inheritance tax, capital gains tax and income tax. But lawyers representing bereaved families have since discovered that this only applies to the first transfer of money from a victim's estate. If the money went to a victim's spouse or civil partner and they then passed it on to their children, that would be a second transfer and could be subject to inheritance tax at 40 per cent. For the compensation to go to a child or someone other than a spouse inheritance tax-free, that recipient would have to be specified in the victim's will as the beneficiary of the first transfer — not something that is possible for the children of victims who have died. It is estimated that 30,000 victims were given blood infected with HIV, hepatitis B or hepatitis C by the NHS between the 1970s and early 1990s. More than 3,000 people have died as a result. Thousands of sub-postmasters were wrongly accused of taking money from their tills between 1999 and 2015when a glitch in the Horizon accounting software was really to blame. Some £13.6 billion was set aside for compensation to victims across both scandals. Jade Gani from the Association of Lifetime Lawyers, a trade body for those who represent older and vulnerable people, said: 'It is a massive flaw in the system that families who have already lost so much could now have to pay back significant sums to the body ultimately responsible for the scandal.' The infected blood scandal is widely considered to be the biggest treatment disaster in the history of the NHS. Thousands of patients were given contaminated blood after accidents, during childbirth or medical procedures. Patients were also given treatments that contained infected blood. About 6,000 people who suffered from haemophilia, a condition that prevents the blood from clotting properly, and other bleeding disorders received treatments to replace missing clotting agents that were made from contaminated blood plasma. In May 2024 the prime minister Rishi Sunak apologised for a 'decades-long moral failure' and promised to pay 'whatever it costs' to compensate victims. More than £11.8 billion was set aside, which included money for infected victims and those affected by the scandal, such as partners and children. The government has paid £1.5 billion to victims since payments began in December. Payments were said to be protected from inheritance tax, but it has now emerged that this only applied to the first transfer. This is not an issue for victims who get their compensation during their lifetime because they can change their will so that family members are mentioned as first transfer beneficiaries of the compensation and so won't have to pay tax on it. • Infected blood judge angered by slow and 'unjust' compensation But the payments to victims who have already died, which are due to begin later this year, will only be inheritance tax-free for the first-transfer beneficiary — usually a spouse or civil partner who can inherit their partner's estate inheritance tax-free anyway. The first £325,000 value of an estate is free from inheritance tax (£500,000 if it is worth less than £2 million and includes a main home left to a direct descendant). Spouses or civil partners can inherit without paying inheritance tax, and they can also inherit each other's allowances, meaning a couple can pass on up to £1 million inheritance tax-free. With some blood scandal compensation payments set to hit £2 million and many in line to get about £1 million, it is likely that most victims' estates will breach the allowances. Anything left in an estate above the tax-free allowance can be taxed at 40 per cent. The decades-long delays to compensation payments mean many surviving beneficiaries are now in their eighties and nineties, and will not have enough time to give away their money tax-free. Gifts fall out of your estate for inheritance tax purposes if you live for seven years after they are made. If you live for three to seven years then anything above your allowances is taxed on a sliding scale. Die before three years and it will remain part of your estate and may be taxed at the full 40 per cent inheritance tax rate. It was reported on Wednesday that the chancellor was considering scrapping the seven-year rule or extending the seven years to ten or beyond. Ben Bell from the Society of Trust and Estate Practitioners, a trade group for inheritance planners, said: 'This is a major injustice. Parliament made provision for the payments to be exempt from inheritance tax, but the delay in making the payments means that the government will, in many cases, get 40 per cent of the payments back in inheritance tax.' Owen McLaughlin's father, Steve, was born with haemophilia and died in 1989 aged 34 after being given blood plasma infected with HIV. 'My father has never met my wife, he never met my kids. All the important events in my life, he wasn't there,' said Owen, 55, from Exeter. Steve left everything to his wife, Pam, who is now 80 and suffering from a number of health conditions, including multiple sclerosis. She expects to get more than £500,000 in compensation and wants to pass it on to her two sons and six grandchildren, but will then need to survive at least seven years if they are to fully escape inheritance tax. 'It is unfair because if my dad had known there would be this future compensation and the tax rules would be as they are, he would have written his will differently,' Owen said. 'It is completely immoral that the government can pay compensation for a frankly heinous act and then think about immediately taking it back through inheritance tax.' Chris Wood's father, John, was infected with HIV in 1982 after being given blood during a triple heart bypass operation to treat his angina. He lived with the disease for years without knowing, before getting seriously ill during the Christmas of 1992 and being admitted to hospital. He died three weeks later, devastating Chris and his two sisters. Chris's, mother Rita, who is 91, will inherit John's compensation and wants to give it to her children straight away but with her estate worth more than her IHT-free allowances the family face having to pay back £360,000 if she dies within three years. 'I understand it has to stop somewhere, but the exemption should carry through to immediate family,' said Chris, 53, from Chelmsford in Essex. 'We could have to pay back 40 per cent of what we get within a year or two — it's a kick in the teeth after all we have been through.' About 700 sub-postmasters were convicted of offences including fraud, false accounting and theft based on incorrect information provided by the Horizon accounting system. Some went to prison and thousands more were wrongly accused. With the earliest cases now 26 years ago and compensation still being paid, the victims are facing similar inheritance tax worries. Stephen Lewis from the law firm Schofield and Sweeney, which represents 50 sub-postmasters, said that while there would be fewer families affected than with the infected blood scandal, inheritance tax was an issue. 'I anticipate there will be a sizeable element that this could affect just by the fact that we are dealing with compensation for events from up to 25 years ago,' he said. A third of the 10,814 Post Office victims are still waiting for compensation, and at least 345 died before being compensated. Neil Hudgell from the law firm Hudgell Solicitors, which represents 1,000 sub-postmasters, said: 'Compensation ought to be treated holistically as to the close family unit, and there shouldn't be any tax payable on the first or second transfers after compensation is paid.' The Association of Lifetime Lawyers and Society of Trust and Estate Practitioners has written to HM Revenue & Customs about the issue in a push for change. A beneficiary of a will has the option to redirect money to new beneficiaries if they choose through a deed of variation. If done within two years of death, the change will be treated as if the deceased included them in the original will, meaning that compensation could be exempt from inheritance tax. This, however, is not an option for the beneficiaries of many infected blood victims, who died more than two years ago. The Association wants the two-year limit to begin on payment of compensation, rather than death, which would give the initial beneficiary time to ensure that family members benefit from the tax exemption. Gani said: 'Many victims have paid the ultimate price with their lives and now, unless the law changes, their families are forced to pay again; this time to the taxman.' The government said: 'While no amount of compensation will make up for the suffering people have endured, we are committed to delivering compensation as swiftly as possible. 'Victims' compensation is exempt from inheritance tax when applied to the estate of the person to whom the compensation payment was made, and this relief will not extend to subsequent beneficiaries of the deceased person's estate.'
South Wales Guardian
3 hours ago
- South Wales Guardian
Andrew Flintoff backs campaign to increase helipads at hospitals
In December 2022, Flintoff sustained severe injuries while filming at the Dunsfold Aerodrome in Surrey for an episode of BBC show Top Gear. The former international cricketer was airlifted to St George's Hospital in Tooting – a major trauma centre. The helipad at the hospital was funded by a campaign with the Helicopter Emergency Landing Pads (Help) Appeal. As he backed the campaign, Flintoff said: 'When I was airlifted, that helipad wasn't just a safe spot to land on the hospital roof, it was a vital step in giving me a second chance as I had immediate access to the specialist care which helped saved my life. 'As every cricket pitch has a wicket, every hospital that needs one should have a helipad.' The Help Appeal said that there have been 30,000 landings on the 32 NHS hospital helipads funded by the charity across the country. It has also funded 23 major upgrades at other hospital helipads. The charity is aiming to fund 40 new and upgraded helipads. Robert Bertram, chief executive of the Help Appeal, said: 'We are incredibly grateful to have Freddie's support, especially knowing that his life was saved thanks, in part, to a Help Appeal-funded helipad. His story highlights exactly why the charity's work is so vital – seconds count in a medical emergency and that helipad made all the difference. 'Freddie's backing brings invaluable awareness to the importance of rapid access to emergency care for everyone, everywhere.' Sir Keith Porter, emeritus professor of clinical traumatology at the University of Birmingham, said the charity plays a 'crucial part' in getting patients to the right hospital at the right time. He added: 'Helicopter Emergency Medical Services have the ability to deliver critical care teams at or close to the side of a patient and then to transport them to the most appropriate hospital for their clinical needs, in the case of injury, usually a major trauma centre. 'Minutes count, particularly for patients with life-threatening bleeding, where the extra journey time can make the difference between life and death. 'The Help Appeal, by funding on-site helipads, helps facilitate the prompt delivery of patients directly into the emergency department with a trolley-push from the landing site.' Flintoff also recently visited the NHS staff who cared for him after the accident at St George's Hospital. He praised health workers in the NHS as 'superheroes' and described the aftermath of the crash as the 'the lowest I've ever been'. The 47-year-old praised the 'expertise, love and compassion' shown by staff at the hospital during his time of need. During a documentary about the accident, Flintoff described how he used the split-second decision-making from his cricketing days to try to reduce the impact of the crash. He said he was 'pulled face-down on the runway' for about 50 metres under the car. The former England star said he thought he had died in the accident. For months after the crash, Flintoff disappeared from public view and would leave his house only for medical appointments His recovery has been documented in a documentary, Flintoff, streamed on Disney+.
